234 related articles for article (PubMed ID: 10741006)
1. [Antibody levels for diphtheria, tetanus and pertussis in young adult females immunized with whole cell pertussis-diphtheria-tetanus toxoid vaccine in infancy].
Meno Y; Okada K; Yamaguchi Y; Morokuma K; Okuma K; Ueda K
Kansenshogaku Zasshi; 2000 Feb; 74(2):150-4. PubMed ID: 10741006
[TBL] [Abstract][Full Text] [Related]
2. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD
Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748
[TBL] [Abstract][Full Text] [Related]
4. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
[TBL] [Abstract][Full Text] [Related]
5. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.
Hanvatananukul P; Prasarakee C; Sarachai S; Aurpibul L; Sintupat K; Khampan R; Saheng J; Sudjaritruk T
Int J Infect Dis; 2020 Jul; 96():422-430. PubMed ID: 32387447
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine.
Ramsay ME; Rao M; Begg NT; Redhead K; Attwell AM
Lancet; 1993 Jul; 342(8865):203-5. PubMed ID: 8100929
[TBL] [Abstract][Full Text] [Related]
8. [Immunity of children aged 6-8 against pertussis, tetanus and diphtheria].
Slusarczyk J; Dulny G; Nowak K; Krszyna J; Wysokińska T; Fordymacka A; Gzyl A; Janaszek W; Gniadek G
Przegl Epidemiol; 2002; 56(1):39-48. PubMed ID: 12150066
[TBL] [Abstract][Full Text] [Related]
9. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.
Rennels MB; Deloria MA; Pichichero ME; Losonsky GA; Englund JA; Meade BD; Anderson EL; Steinhoff MC; Edwards KM
Pediatrics; 2000 Jan; 105(1):e12. PubMed ID: 10617749
[TBL] [Abstract][Full Text] [Related]
10. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age.
Avendano A; Ferreccio C; Lagos R; Horwitz I; Cayazzo M; Fritzell B; Meschievitz C; Levine M
Pediatr Infect Dis J; 1993 Aug; 12(8):638-43. PubMed ID: 8414775
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
[TBL] [Abstract][Full Text] [Related]
13. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT
BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015
[TBL] [Abstract][Full Text] [Related]
14. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
[TBL] [Abstract][Full Text] [Related]
15. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
[TBL] [Abstract][Full Text] [Related]
16. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
17. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
[TBL] [Abstract][Full Text] [Related]
18. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
Sato H; Sato Y
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Kheirkhah T; Ghazanfari M; Shokri F
Iran J Immunol; 2007 Jun; 4(2):101-9. PubMed ID: 17652850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
